Overabundance of gut bacteria may exacerbate pain in patients with sickle cell disease

An overabundance of the bacteria Veillonella in the digestive tract may increase pain in patients with sickle cell disease (SCD). Researchers from Howard University will present their findings today at the American Physiological Society's Physiological and Pathophysiological Consequences of Sickle Cell Disease conference in Washington, D.C.

Previous studies have reported that Veillonella, a bacterium that normally lives in the mouth and gut, forms a film in the gastrointestinal tract. Streptococcus bacteria may attach themselves to this film, making them stronger and more virulent. Streptococcus is responsible for diseases such as strep throat, meningitis and bacterial pneumonia.

The researchers studied fecal DNA of people with SCD and found they had higher levels of Veillonella in the gut than a control group of healthy people did. In addition, all of the SCD patients in the trial had been hospitalized in the previous year-;some multiple times-;for vaso-occlusive crisis (VOC), a severe pain event common in SCD. VOC occurs when the misshapen, sickled red blood cells block blood flow in the blood vessels. Overgrowth of Veillonella "might exacerbate pain crises primarily due to blood vessels occlusion," the research team wrote. Red blood cells might attach to the film of Veillonella and cause increased pain, explained Hassan Brim, PhD, first author of the study. More research is needed to determine how to best rebalance the bacteria in the digestive tract and potentially reduce symptoms, Brim noted.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single-cell genomics unveils secrets of the human microbiome